Detalhe da pesquisa
1.
Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001.
Int J Gynecol Cancer
; 32(1): 93-100, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34799418
2.
Rapidly Progressive Lung Sarcomatoid Carcinoma Managed with Doxorubicin Plus Ifosfamide and Pemetrexed.
Case Rep Oncol
; 14(3): 1677-1681, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35082625
3.
Real-World Evidence: Multicenter Efficacy and Toxicity Analysis of Nintedanib With Docetaxel as Second-Line Treatment in Mexican Patients With Advanced Lung Adenocarcinoma.
JCO Glob Oncol
; 6: 462-470, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32196388
4.
Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP).
J Thorac Oncol
; 10(5): 838-843, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25634006